COMMUNIQUÉS West-GlobeNewswire

Sienna Biopharmaceuticals to Present at Jefferies Healthcare Conference
31/05/2018
WESTLAKE VILLAGE, Calif., May 31, 2018 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (NASDAQ: SNNA ) today announced that Frederick C. Beddingfield III, M.D., Ph.D., President and Chief Executive Officer of Sienna [...]
On “Grindeks” results in the first three months of 2018
31/05/2018
Today, on 31 May, the JSC “Grindeks” submitted the non-audited consolidated financial statements for the first three months of 2018 to “Nasdaq Riga”. Non-audited financial results indicate the turnover of the Group in [...]
Cannabis Wheaton Announces Closing of $115 Million Bought Deal Financing and Exercise in Full of Underwriters’ Over-Allotment Option
31/05/2018
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION TO UNITED STATES VANCOUVER, B.C., May 31, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (TSX.V:CBW) (“ Cannabis Wheaton ” or the " [...]
ICC Labs Files Financial Results for the First Quarter Ended March 31, 2018
31/05/2018
VANCOUVER, British Columbia, May 31, 2018 (GLOBE NEWSWIRE) -- ICC Labs Inc. (“ICC Labs” or the “Company”) (TSX-V: ICC ) (Frankfurt: 2Q9 ) is pleased to announce it has filed its interim financial results for the first [...]
Emisphere Development Update
31/05/2018
ROSELAND, N.J., May 31, 2018 (GLOBE NEWSWIRE) -- Novo Nordisk (NYSE: NVO ) announced Tuesday the completion of the second phase 3a trial, PIONEER 2, with oral semaglutide, a once-daily oral formulation of the long- [...]
Progenics Pharmaceuticals to Present at the Jefferies 2018 Healthcare Conference
31/05/2018
NEW YORK, May 31, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX ), an oncology company developing innovative medicines and imaging technology for targeting and treating cancer, announced today [...]
CV Sciences, Inc. Supports World No Tobacco Day on May 31, 2018
31/05/2018
LAS VEGAS, May 31, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. , (OTCQB:CVSI) (the "Company," "CV Sciences," "our" or "we"), is pleased to announce its support in highlighting the World Health Organization (WHO) and its [...]
Abeona Therapeutics Announces Opening of Commercial Gene & Cell Therapy Manufacturing Facility in Ohio
31/05/2018
-- The Elisa Linton Center for Rare Disease Therapies to support development of advanced gene and cell therapies for treatment of serious rare diseases -- Ribbon-cutting ceremony of gene and cell therapy GMP production [...]
Hemispherx Biopharma and Roswell Park Plan Phase I/II Study of Ampligen Plus Checkpoint Inhibitors
31/05/2018
Earlier Studies Showed Ampligen Produced a More Favorable Ratio of Killer T cells to Regulatory T cells in the Tumor Microenvironment, a Key to Improving Checkpoint Blockade Therapy ORLANDO, Fla., May 31, 2018 (GLOBE [...]
Histogenics Corporation to Host Investor Day on June 19, 2018
31/05/2018
WALTHAM, Mass., May 31, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Nasdaq: HSGX ), a leader in the development of restorative cell therapies that may offer rapid-onset pain relief and restored function, announced [...]
Cutera Announces Opening of New Office and Training Center in Madrid to the Newly Established Direct Operations in Spain
31/05/2018
MADRID, Spain, May 31, 2018 (GLOBE NEWSWIRE) -- CUTERA, INC., (Nasdaq: CUTR ) (“Cutera” or the “Company”) a leading provider of laser, light and other energy-based aesthetic systems for practitioners worldwide, [...]
Progenics’ Artificial Intelligence Technology for Automated Analysis of PSMA Targeted Prostate Cancer Images to be Featured at the 2018 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting
31/05/2018
NEW YORK, May 31, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX ), an oncology company developing innovative medicines and imaging technology for targeting and treating cancer, announced today [...]
Precision Therapeutics Launches New Website
31/05/2018
MINNEAPOLIS, May 31, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT ) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery [...]
scPharmaceuticals Inc. Provides Regulatory Update on FUROSCIX®
31/05/2018
BURLINGTON, Mass., May 31, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH ), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of [...]
Zealand Pharma to present new clinical Phase 2 results on glepaglutide for the treatment of short bowel syndrome at the DDW conference in the U.S.
31/05/2018
Press Release - No. 14/2018 Z ealand Pharma to present new clinical Phase 2 results on glepaglutide for the treatment of short bowel syndrome at the DDW conference in the U.S. The results demonstrates glepaglutide's [...]
GTX Corp on Capitol Hill advocating for Kevin and Avonte’s Law and seeking new UN Market Opportunities
31/05/2018
LOS ANGELES, May 31, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB: GTXO ), an IoT platform and global provider of GPS tracking and monitoring wearable and wandering assistive technology, went to Capitol Hill to meet with [...]
Catalyst Pharmaceuticals to Present at the Jefferies 2018 Global Healthcare Conference
31/05/2018
CORAL GABLES, Fla., May 31, 2018 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX ), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with [...]
New Jersey Plastic Surgeon Says Xact Technology Offers a Less Invasive Alternative to Facelift Surgery
31/05/2018
Dr. Christopher Godek, the Medical Director of the Personal Enhancement Center, says the Xact device can help many patients who are looking for an effective alternative to invasive facelift surgery. Dr. Godek recently [...]
Iovance Biotherapeutics to Present at Two Investor Conferences in June
31/05/2018
SAN CARLOS, Calif., May 31, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA ), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology [...]

Pages